Sutro Biopharma (STRO) Treasury Shares (2017 - 2025)

Sutro Biopharma has disclosed Treasury Shares across 9 years of filings, most recently posting $417772.0 for Q4 2025.

• Treasury Shares for Q4 2025 came in at $417772.0, down 29.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $417772.0 (down 29.87% YoY), and the FY2025 annual result was $417772.0, down 29.87% from the prior year.
• Treasury Shares came in at $417772.0 for Q4 2025 at Sutro Biopharma, down from $5.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $6.2 million in Q2 2025 to a low of $417772.0 in Q4 2025.
• The 5-year median for Treasury Shares is $3.9 million (2022), against an average of $4.0 million.
• Across the five-year window, Treasury Shares surged 260.73% in 2021 and plunged 88.64% in 2024, its largest moves.
• Sutro Biopharma's Treasury Shares stood at $2.4 million in 2021, then jumped by 64.67% to $4.0 million in 2022, then surged by 32.5% to $5.2 million in 2023, then slumped by 88.64% to $595691.0 in 2024, then dropped by 29.87% to $417772.0 in 2025.
• The last three Treasury Shares figures came in at $417772.0 (Q4 2025), $5.2 million (Q3 2025), and $6.2 million (Q2 2025), per Business Quant data.